1.1.9.2.10.3.7– Bibliografia Temática. Referências Bibliográficas sobre o HIV.
1.
Alison J.
Rodger et al. Sexual Activity Without Condoms and Risk of HIV Transmission in
Serodifferent Couples When the HIV-Positive. Partner Is Using Suppressive
Antiretroviral Therapy. JAMA. 2016;316(2):171-181
2.
Brasil.
Ministério da Saúde. [www.aids.gov.br/documentos/publicações] – busca:
conscritos do exército do Brasil, 2002
3.
Brasil.
Ministério da Saúde. PN-DST/AIDS. Estudo de prevalência das DST no Brasil.
Mimeo. 2004a.
4.
Brasil.
Ministério da Saúde, [www.aids.gov.br/areatecnica/monitoraids/estudosespeciais]
VII Pesquisa de Conhecimentos, atitudes e Práticas relacionadas ao HIV/aids com
a População Brasileira de 15 a 54 anos – 2004b,
5.
Brasil.
Ministério da Saúde. Norma Técnica de Prevenção e Tratamento dos Agravos
Resultantes da Violência Sexual contra Mulheres e Adolescentes. Brasília, 2004c.
6.
Brasil.
Ministério da Saúde. Boletim Epidemiológico DST e AIDS, ano II n.01-01 à 26a.
semanas epidemiológicas – jan a jun de 2005.
7.
Bowden
FJ, Garnett GP. Trichomonas vaginalis epidemiology: parameterising and
analyzing a model of treatment interventions. Sex Transm Inf, 2000, 76:
248-256.
8.
Brasil.
Portaria no 542/1986. Diário Oficial da República Federativa do Brasil,
Brasília, 24 de Dezembro de 1986, Seção 1.
9.
Carvalho
M, de Carvalho S, Pannuti CS, Sumita LM, de Souza VA. Prevalence of herpes
simplex type 2 antibodies and a clinical history of herpes in three different
populations in Campinas City, Brazil. Int J Infect Dis. 1998-99
Winter;3(2):94-8.
10. CEBRAP, Ministério da Saúde. Relatório da pesquisa “Comportamento
Sexual da População Brasileira e Percepções do HIV/AIDS “. São Paulo, setembro
de 2000.
11. Centers for Disease Control and Prevention (CDC).
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the
United State through childhood vacination. Recommendations of the Advisory Committee
on Immunization Practices. A C.I.P. MMWR 42: 1-13, 1993.
12. Centers for Disease Control and Prevention (CDC).
Increase in fluoroquinolone-resistant Neisseria gonorrhoeae – Hawaii and
California, 2001. MMWR,2002;51(46):1041-44.
13. Centers for Disease Control and Prevention (CDC).
Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002
May 10;51(RR-6):1-78.
14. Centers for Disease Control and Prevention (CDC).
Azithromycin treatment failures in syphilis infections--San Francisco, California,
2002-2003. MMWR Morb Mortal Wkly Rep. 2004a Mar 12;53(9):197-8.
15. Centers for Disease Control and Prevention (CDC).
Lymphogranuloma venereum among men who have sex with men--Netherlands,
2003-2004. MMWR Morb Mortal Wkly Rep. 2004b Oct 29;53(42):985-8.
16. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR,
Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ Jr. Reduction of
concentration of HIV-1 in semen after treatment of urethritis: implications for
prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.
Lancet. 1997 Jun 28; 349 (9069): 1868-73.
17. Corey L, Ashley R; Valacyclovir HSV Transmission
Study Group. Prevention of herpes simplex virus type 2 transmission with
antiviral therapy. Herpes. 2004 Aug;11 Suppl 3:170A-174A.
18. Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC,
LI H, Bandeira MG, dos Santos Fernando Filho E. Reduced susceptibility to
azythromycin and high percentages of penicillin and tetracycline resistance in
Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex Transm Dis 2001,
28(9): 521-6.
19. Elley A, Pacey AA, Galdeiro M, Galdeiro M, Galdeiro
F. Can Chlamydia trachomatis directly damage your sperm? Lancet Infect Dis.
2005 Jan;5(1):53-7.
20. Ferreira WA, Ferreira CM, Schettini APM, Sardinha
JCG, Benzaken AS, Garcia MA, Garcia EG. Neisseria gonorrhoeae produtoras de
betalactamase resistentes a azitromicina em Manaus, Amazonas, Brasil. DST- J
Bras Doenças Sex Transm, 2004; 16(2):28-32.
21. Fioravante FC, Costa Alves Mde F, Guimaraes EM,
Turchi MD, Freitas HA, Domingos LT. Prevalence of Chlamydia trachomatis in
asymptomatic Brazilian military conscripts. Sex Transm Dis. 2005
Mar;32(3):165-9.
22. Fleming DT, Wasserheit JN. From epidemiological
synergy to public health policy and practice: the contribution of other
sexually transmitted diseases to sexual transmission of HIV infection. Sex
Transm Infect. 1999 Feb;75(1):3-17.
23. Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V,
Coulibaly IM, Yeboue KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, Laga
M. The associations between cervicovaginal HIV shedding, sexually transmitted
diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire.
AIDS. 1997 Oct;11(12):F85-93.
24. Gutman, L. Gonococcal diseases in infants and
children. In: Holmes et al., eds. Sexually transmitted diseases. New York:
McGraw-Hill Inc, 1999: 1146,Table 82-1.
25. Harper DM, Franco EL, Wheeler C, et al. Vaccination
against human papillomavirus shows great promise. The Lancet 2004;
364(9447):1731-1732/1757-1765.
26. Holmes KK. Azitromycin versus penicillin for early
syphilis.N Engl J Med 2005;305(12):1291-3.
27. http://www.pnvihsida.dgs.pt/ (consultado em 1 de
Novembro de 2018)
28. http://www.sermais.pt/ (consultado em 1 de Novembro
de 2018)
29. http://www.eacsociety.org/files/2018_guidelines-9.1-english.pdf
(consultado em 1 de Novembro de 2018)
30. http://gesida-seimc.org/ (consultado em 1 de
Novembro de 2018)
31. http://www.aidsmap.com (consultado em 1 de Novembro
de 2018)
32. https://infosida.nih.gov/ (consultado em 1 de
Novembro de 2018)
33. https://aidsinfo.nih.gov/guidelines (consultado em
1 de Novembro de 2018)
34. http://www.unaids.org/en (consultado em 1 de
Novembro de 2018)
35. https://www.healthline.com/health/hiv-aids/how-hiv-affects-the-body
( consultado em 1 de Novembro de 2018)
36. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A
Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm
delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189:139-47.
37. Leone P. Asymptomatic shedding in the transmission,
prevention, and treatment of genital herpes. Medscape Infectious Diseases, 2004;6(1)
38. Mardh PA. Tubal factor infertility, with special
regard to chlamydial salpingitis. Curr Opin Infect Dis. 2004 Feb;17(1):49-52.
39. Manual de Controle de Doenças Sexualmente
Transmissíveis – DST 4ª edição [Link Livre para o Documento Original] - Série
Manuais n. 68. MINISTÉRIO DA SAÚDE. Secretaria de Vigilância em Saúde. Programa
Nacional de DST e Aids. Brasília / DF – 2006
40. McDonald H, Brocklehurst P, Parsons J. Antibiotics
for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2005
Jan 25;(1): CD000262.
41. Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K
Prevalence and risk behaviors for chlamydial infection in a population-based
study of female adolescents in Brazil. Sex Transm Dis. 2004 Sep;31(9):542-6.
42. Moherdaui F, Vuylsteke B, Siqueira LF, dos Santos
Junior MQ, Jardim ML, de Brito AM, de Souza MC, Willers D, Sardinha JC,
Benzaken AS, Ramos MC, Bueno H, Rodrigues LG, Chequer PJ. Validation of
national algorithms for the diagnosis of sexually transmitted diseases in
Brazil: results from a multicentre study. Sex Transm Infect. 1998 Jun;74 Suppl
1:S38-43.
43. Moodley P, Sturm AW. Ciprofloxacin –resistant
gonorrhoea on the rise in South Africa. Lancet 2005;366:1159.
44. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, Dees J,
Thio HB, Thomeer MG, Den Hollander JC, Neumann MH, Van Der Meijden WI.
Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of
Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who
have sex with men. Clin Infect Dis. 2004 Oct 1;39(7):996-1003. Epub 2004 Sep
08.
45. Passos MRL; Benzaken AS; Coelho ICB; Rodrigues GHS;
Dutra JR JC; Varella R; Tavares RR; Barreto NA; Marques BP; Figueiredo J.
Estudo de equivalência entre azitromicina e penicilina G benzatina no
tratamento da sífilis. DST- J Bras Doenças Sex Transm 2004; 16(1):52-66.
46. Passos MRL, Nahn EPJr, Almeida GLF. Cancro Mole,
in: Deesetologia, DST5 Mauro Romero Leal Passos - 5 ed. Rio de Janeiro: Cultura
Médica, 2005 pag. 245-256.
47. Pinkerton SD, Abramson PR, Turk ME. Update
estimates of condom effectiveness 1998. Journal of the Association of Nurses in
Aids care. 9(6):88.
48. Rodriguez MDM, Obasi A, Mosha F, Todd J, Brown D,
Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R. herpes simplex vírus
type 2 infection increses HIV incidence: a prospective study in rural Tanzânia.
AIDS, 2002; 16:451-462.
49. Sangani P, Rutherford G, Wilkinson D.
Population-based interventions for reducing sexually transmitted infections,
including HIV infection. Cochrane Database Syst Rev. 2004;(2):CD001220.
50. Schwebke JR. Diagnostic methods for bacterial
vaginosis. Int J Obstet Gynecol, 1999; 67:S21-23.
51. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim
D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos
CA, Quinn TC, Konde-Lule J. HIV-1 infection associated with abnormal vaginal
flora morphology and bacterial vaginosis. Lancet. 1997 Aug 23;350(9077):546-50.
Erratum in: Lancet 1997 Oct 4;350(9083):1036.
52. Vuylsteke B. Current status of syndromic management
of sexually transmitted infections in developing countries. Sex Transm Infect.
2004 Oct;80(5):392-4.
53. Kapiga SH, Vuylsteke B, Lyamuya EF, Dallabetta G,
Laga M. Evaluation of sexually transmitted diseases diagnostic algorithms among
family planning clients in Dar es Salaam, Tanzania. Sex Transm Infect. 1998 Jun;74
Suppl 1:S132-8.
54. Karinen L, Pouta A, Hartikainen AL, Bloigu A,
Paldanius M, Leunonen M, Saikku P, Jarvelin MR. Association between Chlamydia
trachomatis antibodies and subfertility in the Northern Finland Birth Cohort
1966 (NFBC 1966), at the age of 31 years. Epidemiol Infect. 2004
Oct;132(5):977-84.
55. Kiddugavu MG, Kiwanuka N, Wawer MJ, Serwadda D,
Sewankambo NK, Wabwire-Mangen F, Makumbi F, Li X, Reynolds SJ, Quinn TC, Gray
RH; The Rakai Study Group.Effectiveness of syphilis treatment using
azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis.
2005 Jan;32(1):1-6.
56. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC,
Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, vanDorsten JP,
Dombrowski MP; National Institute for Child Health and Development Maternal
Fetal Medicine Units Network. Time course of the regression of asymptomatic
bacterial vaginosis in pregnancy with and without treatment. Am J Obstet
Gynecol, 2004 190(2) 363-70.
57. www.gatportugal.org
(consultado em 1 de Novembro de 2018)
58. www.kidney.org/news/ekidney/august14/10_Signs_You_May_Have_Kidney_Disease
(consultado em 1 de Novembro de 2018)
59. www.nhlbi.nih.gov/health/health-topics/topics/hdw/signs
(consultado em 1 de Novembro de 2018)
60. www.medicinenet.com/liver_disease/article.htm#what_is_liver_disease
(consultado em 1 de Novembro de 2018)
61. Watts DH; Brown ZA;
Money D; Selke S; Huang, MI; Sacks MI; Corey L. A double-blind , randomized,
placebo-controlled trial of acyclovir in late pregnancy in women for the
reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet
Gynecol 2003; 188:836-43.
62. Watson EJ,
Templeton A, Russel I, Paavonen J, Mardh P-A, Stary A, Stray Pederson B. The
accuracy and efficacy of screening tests for Chlamydia trachomatis: a
systematic review. J Med Microbiol, 2002; 51:1021-31.
63. WendelL GD Jr,
Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and
desensitization in serious infections during pregnancy. N Engl J Med. 1985 May
9;312(19):1229-32.
64. Wilkinson D,
Ruterford G. Intervenciones poblacionales para la reduccion de infecciones de
transmission sexual, incluída la infeccion por VIH. (Revision Cochrane
traducida) La Cochrane Library plus in español, número 3, 2004. Oxford, Update
Software Limited.
65. Wilkinson D, Ramjee
G, Tholandi M, Ruterford G. Nonoxynol-9 for preventing vaginal acquisition of
sexually transmitted infection by women from men. The Cochrane Library, Issue
4, 2004. Chichester, UK: John Wiley & Sons Ltd.
66. World Health
Organization - Sexually Transmited Diseases: Policies and principles for
prevention and care. WHO/UNAIDS, 1997.
67. World Health
Organization - Guidelines for the management of sexually transmitted
infections. 2003.
68. World Health
Organization. Global Strategy for STI Prevention and Control Meeting. Geneva, Nov.
2004.
69. World Health
Organization - Sexually Transmited and Other reproductive tract infections. A
guide to essential practice. 2005.
Nenhum comentário:
Postar um comentário